SecBot SecBot
8-K ·Filed Nov 5, 2026

ALGN

ALIGN TECHNOLOGY INC
NEUTRAL
Impact 4/10
Horizonweeks Processed11d ago SEC0001097149-26-000085
8-K material event: Items 1.01
Actionable Insight • Neutral

The ASR signals management's confidence in Align's cash generation and long-term value, but with no financial results or guidance changes, the impact is limited to capital allocation. Monitor the next quarterly report for updates on share count reduction and any changes to the remaining $330 million authorization.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$166.00
T+0 close · Nov 5, 2026 · via day close
Latest settled
+1.40%
T+5 · $168.32
Vs SPY
−1.20%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $166.00entry
  2. T+1 · 8d ago +4.98%α +2.61% · $174.26
  3. T+5 · 4d ago +1.40%α −1.20% · $168.32
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Align Technology entered into a $270 million accelerated share repurchase (ASR) agreement with Goldman Sachs, funded by cash on hand. The ASR fulfills a prior commitment and brings total 2026 buybacks to approximately $500 million, with $330 million remaining under the existing $1.0 billion program.

Key Facts

  • Align Technology entered into an accelerated share repurchase (ASR) contract with Goldman Sachs on November 5, 2026.
  • The ASR is for $270 million of common stock under the existing $1.0 billion stock repurchase program approved in April 2025.
  • Align will make a $270 million prepayment and receive an initial delivery of approximately 1.44 million shares.
  • Final settlement is expected by December 29, 2026.
  • The ASR fulfills a share repurchase commitment announced in July 2026 and brings total 2026 repurchases to approximately $500 million.
  • As of September 30, 2026, Align had approximately $1.145 billion in cash and cash equivalents.
  • Approximately $330 million remains available for future repurchases under the program.
  • The ASR will be funded with cash on hand.

Financial Impact

$270 million prepayment for share repurchase, funded from $1.145 billion cash balance.

cashshares outstanding

Risk Factors

  • The ASR creates a $270 million cash outflow, reducing financial flexibility.
  • Final share count depends on volume-weighted average price during the repurchase period, introducing uncertainty in the exact dilution reduction.
  • The CEO transition announced on October 28, 2026 adds management transition risk, though this filing is a routine capital allocation move.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001097149-26-000085
Exhibit: exhibit991algn_asrxpressre.htm0001097149-26-000085
Document: 0001097149-26-000085-index-headers.html0001097149-26-000085
Document: 0001097149-26-000085-index.html0001097149-26-000085
Document: 0001097149-26-000085.txt0001097149-26-000085

Track record

19 reports on ALGN

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +12.30% at T+60 after the Aug 3, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $168.32 Now $168.32 +0.00% settles Dec 14
  2. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $172.08 Now $168.32 −2.19% settles Dec 10
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Viewing Entry $166.00 Now $168.32 +1.40% settles Dec 7
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $159.37 Now $168.32 +5.62% settles Dec 4
  5. Nov 2, 202614d ago 3 Neutral 1/10 Entry $151.58 Now $168.32 +11.04% settles Dec 2
  6. Oct 28, 202619d ago 8-K Neutral 3/10 Entry $153.71 Now $168.32 +9.50% settles Nov 27
  7. Oct 28, 202619d ago 8-K Neutral 5/10 Entry $153.71 Now $168.32 +9.50% settles Nov 27
  8. Oct 21, 202627d ago PTAB Trial Mixed 6/10 Entry $155.51 Now $168.32 +8.24% settles Nov 19
  9. Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $148.90 to $165.98 Now $168.32 −13.04% ▼ −11.47% −14.93% vs SPY
  10. Aug 31, 202611w ago 8-K Neutral 2/10 Entry $154.96 to $145.35 Now $168.32 +8.62% ▼ −6.20% −6.52% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (11h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026